secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2022-04-28T23:59:59+00:00
Accession:  0001437749-22-009967
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife reports Q1 net loss of $0.2M on revenue $30.4M; backlog grows to $91.9M
--------------------------------------------------------------------------------

- Revenue $30.4M (+16.9% YoY); net loss $0.2M ($0.01 diluted) vs net income $0.7M ($0.04) in Q1 2021.
- Battery & Energy Products sales up 31.8% to $29.2M, including $6.4M from Excell acquisition.
- Communications Systems sales down 68.3% to $1.2M due to supply chain disruptions delaying shipments.
- Gross margin fell to 22.9% from 26.9% on input cost inflation and higher logistics costs.
- Backlog reached $91.9M; $73.8M expected to ship in 2022, up 26% from prior quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774922009967/0001437749-22-009967-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774922009967/ulbi20220427_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-009967

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer